Pfizer says its experimental pill for COVID-19 cut rates of hospitalization and death nearly 90-percent among patients with mild to moderate infections. The company announced Friday it will soon ask the Food and Drug Administration and international regulators to authorize its pill, which is taken twice a day for five days. Fond du Lac County Public Health Officer Kim Mueller says all therapies now authorized in the U.S. require an IV or injection. Mueller says drugmakers around the world have been racing to develop an easy to use pill to blunt the effects of COVID-19.
